Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04702542 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 21, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Re-verified, no change to tracked fieldsv6
  2. Notable Start date: Jan 4, 2020 to Apr 30, 2022v5
  3. Minor Re-verified, no change to tracked fieldsv4
  4. Minor Secondary endpoints: details revised at 1 of 1 entryv3
  5. Notable Primary completion date: Jun 30, 2021 to Dec 30, 2025
    • Study completion date: Dec 30, 2022 to Dec 30, 2028
    v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The object of the study will be children and adolescents from 6 to 15 years old, living in the city of Tashkent and in the Tashkent region. We will study patients with various clinical forms of chronic gastroduodenal pathology (CGDP). The effect of enteral oxygen therapy in the recovery of patients with CGDP due to the positive effect of the active form of oxygen on the hematological system and on the regenerative processes in the gastrointestinal tract will be studied. At the same time, the effect of enteral oxygen therapy on enhancing the effectiveness of eradication therapy during the treatment of carrier Helicobacter pylori due to the neutralization of the products of urea hydrolysis around bacteria under the action of reactive oxygen species will be studied.
Trial Details
NCT Number NCT04702542
Lead Sponsor Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan
Conditions
(from sponsor)
Gastritis Chronic, Gastroduodenitis, Peptic Ulcer, Duodenal Ulcer
Related terms Duodenal Ulcer, Gastritis, Peptic Ulcer
Enrollment 320 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov